MedTrace Logo

DBS in Treatment Resistant Major Depression

NCT01268137 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2010-12-29

No results posted yet for this study

Summary

This study aims at assessing efficacy and safety of DBS for treatment of patients suffering from resistant major depression, by means of a random, controlled and crossed study.

Conditions

  • Resistant Major Depressive Disorder

Interventions

PROCEDURE

Deep Brain Stimulation

Surgical electrode implantation in the white matter adjacent to the Cg25 region and implantation of the DBS pulse generating device

Sponsors & Collaborators

  • Fondo de Investigacion Sanitaria

    collaborator OTHER

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Perez Sola Víctor, MD · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

  • Molet Joan, MD · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268137 on ClinicalTrials.gov